Yüklüyor......
Fractionated administration of irinotecan and cisplatin for treatment of lung cancer: a phase I study
A combination chemotherapy of irinotecan (CPT-11) and cisplatin (CDDP) has been reported to be active for lung cancer. In the previous trial, however, diarrhoea and leucopenia became the major obstacle for sufficient dose escalation of CPT-11 to improve the treatment outcome. We conducted a phase I...
Kaydedildi:
| Asıl Yazarlar: | , , , , , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Nature Publishing Group
1999
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2362688/ https://ncbi.nlm.nih.gov/pubmed/10070901 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6690157 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|